Literature DB >> 12227724

Adaptation of glutathion-peroxidase activity to oxidative stress occurs in children but not in adult patients with end-stage renal failure undergoing hemodialysis.

O Sommerburg1, T Grune, J H H Ehrich, W G Siems.   

Abstract

Lipid peroxidation (LPO) products formed after reaction of free radicals with membrane lipids are involved in the pathogenesis of cardiac diseases. Also in patients with end-stage renal disease (ESRD) LPO was shown to be accelerated and concentrations of non-enzymatic antioxidants were measured lower than in control subjects. However, up to now only limited knowledge about the role of antioxidant enzymes was available. Whether or not activity of those antioxidants might be induced due to oxidative stress in ESRD patients is not known. To answer the question the activity of 3 enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), and glutathion peroxidase (GPx), was measured in red blood cells of the ESRD patients undergoing hemodialysis (2 groups: children and adults) and matching controls. LPO in these subjects was determined by measurement of the LPO product 4-hydroxynonenal (HNE) in blood plasma. Plasma HNE was significantly increased by factor 3 in both patient groups children and adults compared to the control groups. The activity of the enzymatic antioxidants was measured differently. While SOD was significantly lower in patients (children and adults) than in the matching controls this was not the case for catalase and GPx. While GPx activity in adult patients was comparable to that in the control groups (childrens and adults), the GPx in children with ESRD was almost twice as high than in the other groups. Since children were shown to have higher levels of glutathion, activated GPx might be a sign of adaptation of these children to the increased rate of oxidation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12227724

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  7 in total

1.  Low hair selenium and plasma glutathione peroxidase in children with chronic renal failure.

Authors:  Erol Ortaç; Ozan Ozkaya; Recep Saraymen; Nurdan Yildiz; Abdülkerim Bedir; Necla Buyan; Kenan Bek; Ali Okuyucu; Kemal Baysal
Journal:  Pediatr Nephrol       Date:  2006-08-26       Impact factor: 3.714

2.  Paraoxonase, anti-oxidant response and oxidative stress in children with chronic renal failure.

Authors:  Aydin Ece; Yildiz Atamer; Fuat Gürkan; Mehmet Davutoğlu; Meki Bilici; Murat Tutanç; Ali Güneş
Journal:  Pediatr Nephrol       Date:  2005-10-27       Impact factor: 3.714

3.  Lipid peroxidation and antioxidant enzymes in children with chronic renal failure.

Authors:  Danuta Zwolińska; Władysław Grzeszczak; Katarzyna Kiliś-Pstrusińska; Krystyna Szprynger; Maria Szczepańska
Journal:  Pediatr Nephrol       Date:  2004-06-04       Impact factor: 3.714

4.  Lipid peroxidation and antioxidant enzymes in children on maintenance dialysis.

Authors:  Danuta Zwołińska; Władysław Grzeszczak; Maria Szczepańska; Katarzyna Kiliś-Pstrusińska; Krystyna Szprynger
Journal:  Pediatr Nephrol       Date:  2006-03-04       Impact factor: 3.714

5.  Oxidative stress, inflammation and early cardiovascular damage in children with chronic renal failure.

Authors:  Aydin Ece; Fuat Gürkan; Mehmet Kervancioğlu; Halil Kocamaz; Ali Güneş; Yildiz Atamer; Sahbettin Selek
Journal:  Pediatr Nephrol       Date:  2006-03-07       Impact factor: 3.714

6.  Hypoxia and oxidative stress markers in pediatric patients undergoing hemodialysis: cross section study.

Authors:  Enas A Hamed; Taghrid B El-Abaseri; Amany O Mohamed; Ahmed R Ahmed; Tarek H El-Metwally
Journal:  BMC Nephrol       Date:  2012-10-13       Impact factor: 2.388

7.  Plasma and erythrocyte glutathione peroxidase activity, serum selenium concentration, and plasma total antioxidant capacity in cats with IRIS stages I-IV chronic kidney disease.

Authors:  M Krofič Žel; N Tozon; A Nemec Svete
Journal:  J Vet Intern Med       Date:  2013-12-16       Impact factor: 3.333

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.